AVENCELL

Welcome to the Brand page for “AVENCELL”, which is offered here for Pharmaceutical and biological preparations; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; pharmaceutical preparations, t-cell based therapeutics to treat cancer and autoimmune disease;pharmaceutical research and development; scientific research, development, and analytical services in the field of pharmaceuticals, biopharmaceuticals, gene, genome, and cellular editing, modulation, and modification, and t-cell based therapeutics;.

Its status is currently believed to be active. Its class is unavailable. “AVENCELL” is believed to be currently owned by “AvenCell Therapeutics, Inc.”